Units taught
Post-graduate Medicine
HME101: Medicine 1A Unit Coordinator
Human Biology Topic Coordinator
Under-graduate Medical Biotechnology
HMM103: Cell Technology Unit Chair
Awards
2012 JDRF/Maquarie Group Foundation Early-Stage Researcher Travel Grant
2012 CASS Foundation Early Career Researcher Award
2009 Travel Scholarship, Recent Advances in Beta Cell Biology, International Diabetes Federation and University of Toronto
2006 Travel Scholarship, Australian Diabetes Society
2005 Pincus-Taft Young Investigator Award (Awarded by the Australian Diabetes Society)
2005 Travel Scholarship, Australian Diabetes Society
2005 Sanofi aventis Diabetes Partnership Young Investigator Award: Travel Grant for American Diabetes Association Annual Scientific Meeting 2005
2004 Travel Scholarship, Australian Diabetes Society
2003-2007 Australian Postgraduate Award (Scholarship)
2003 Travel Scholarship, Australian Diabetes Society
Projects
Dr. Aston-Mourney has several projects underway focusing on the insulin-secreting beta cells of the pancreas and their dysfunction in diabetes.
Currently accepting expressions of interest from prospective PhD and Honours students.
Publications
W Naser, S Maymand, L Rivera, T Connor, C Liongue, C Smith, K Aston-Mourney, D McCulloch, S McGee, A Ward
(2022), Vol. 36, FASEB Journal, C1
R Aarthy, K Aston-Mourney, A Mikocka-Walus, V Radha, A Amutha, R Anjana, R Unnikrishnan, V Mohan
(2021), Vol. 35, pp. 1-27, Journal of diabetes and its complications, Amsterdam, The Netherlands, C1
Quality of Life and Diabetes in India: A scoping review
R Aarthy, A Mikocka-Walus, R Pradeepa, R Anjana, V Mohan, K Aston-Mourney
(2021), Vol. 25, pp. 365-380, Indian Journal of Endocrinology and Metabolism, Mumbai, India, C1
Copper ionophores as novel antiobesity therapeutics
P Meggyesy, S Masaldan, S Clatworthy, I Volitakis, D Eyckens, K Aston-Mourney, M Cater
(2020), Vol. 25, pp. 1-15, Molecules, Basel, Switzerland, C1
Class IIa HDACs do not influence beta-cell function under normal or high glucose conditions
Jacob McCann, Megan Ellis, Sean McGee, Kathryn Aston-Mourney
(2019), Vol. 11, pp. 112-118, Islets, Abingdon, Eng., C1
Metformin, beta-cell development, and novel processes following beta-cell ablation in zebrafish
G Wyett, Y Gibert, M Ellis, H Castillo, J Kaslin, K Aston-Mourney
(2018), Vol. 59, pp. 419-425, Endocrine, Totowa, N.J., C1-1
APP deficiency results in resistance to obesity but impairs glucose tolerance upon high fat feeding
J Czeczor, A Genders, K Aston-Mourney, T Connor, L Hall, K Hasebe, M Ellis, K De Jong, D Henstridge, P Meikle, M Febbraio, K Walder, S McGee
(2018), Vol. 237, pp. 311-322, Journal of endocrinology, Bradley Stok, Eng., C1
Gene expression signature: a powerful approach for drug discovery in diabetes
S Sithara, T Crowley, K Walder, K Aston-Mourney
(2017), Vol. 232, pp. R131-R139, Journal of endocrinology, Bristol, Eng., C1
Scriptaid enhances skeletal muscle insulin action and cardiac function in obese mice
V Gaur, T Connor, K Venardos, D Henstridge, S Martin, C Swinton, S Morrison, K Aston-Mourney, S Gehrig, R van Ewijk, G Lynch, M Febbraio, G Steinberg, M Hargreaves, K Walder, S McGee
(2017), Vol. 19, pp. 936-943, Diabetes, obesity and metabolism, Chichester, Eng., C1
B Hayward, J Molero, K Windmill, A Sanigorski, J Weir, N McRae, K Aston-Mourney, B Osborne, B Liao, K Walder, P Meikle, N Konstantopoulos, C Schmitz-Peiffer
(2016), Vol. 124, pp. 602-612, Experimental and clinical endocrinology and diabetes, Munich, Germany, C1
K Aston-Mourney, S Subramanian, S Zraika, T Samarasekera, D Meier, L Goldstein, R Hull
(2013), Vol. 305, American Journal of Physiology: Endocrinology and Metabolism, Bethesda, MD, C1
Adipocytokines as features of the metabolic syndrome determined using confirmatory factor analysis
M Smits, P Woudstra, K Utzschneider, J Tong, F Gerchman, M Faulenbach, D Carr, K Aston-Mourney, A Chait, R Knopp, J Meigs, E Boyko, S Kahn
(2013), Vol. 23, pp. 415-421, Annals of Epidemiology, Amsterdam, Netherlands, C1-1
J Udayassankar, S Zraika, K Aston-Mourney, S Subramanian, B Brooks-Worrell, G Taborsky, R Hull
(2013), Vol. 45, pp. 574-579, Transplantation Proceedings, New York, NY, C1-1
Matrix Metalloproteinase-9 reduces islet amyloid formation by degrading islet amyloid polypeptide
K Aston-Mourney, S Zraika, J Udayasankar, S Subramanian, P Green, S Kahn, R Hull
(2013), Vol. 288, pp. 3553-3559, The journal of biological chemistry, Bethesda, Maryland, C1
S Subramanian, R Hull, S Zraika, K Aston-Mourney, J Udayasankar, S Kahn
(2012), Vol. 55, pp. 166-174, Diabetologia, Heidelberg , Germany, C1-1
B-cell loss and B-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition
C Jurgens, M Toukatly, C Fligner, J Udayasankar, S Subramanian, S Zraika, K Aston-Mourney, D Carr, P Westermark, G Westermark, S Kahn, R Hull
(2011), Vol. 178, pp. 2632-2640, American journal of clinical pathology, Birmingham, Ala., C1-1
K Aston-Mourney, R Hull, S Zraika, J Udayasankar, S Subramanian, S Kahn
(2011), Vol. 54, pp. 1756-1765, Diabetologia, Heidelberg, Germany, C1-1
S Zraika, K Aston-Mourney, P Marek, R Hull, P Green, J Udayasankar, S Subramanian, D Raleigh, S Kahn
(2010), Vol. 285, pp. 18177-18183, Journal of biological chemistry, Bethesda, Md., C1-1
J Udayasankar, K Kodama, R Hull, S Zraika, K Aston-Mourney, S Subramanian, J Tong, M Faulenbach, J Vidal, S Kahn
(2009), Vol. 52, pp. 145-153, Diabetologia, Heidelberg, Germany, C1-1
S Zraika, R Hull, J Udayasankar, K Aston-Mourney, S Subramanian, R Kisilevsky, W Szarek, S Kahn
(2009), Vol. 52, pp. 626-635, Diabetologia, Heidelberg, Germany, C1-1
R Hull, S Zraika, J Udayasankar, K Aston-Mourney, S Subramanian, S Kahn
(2009), Vol. 52, pp. 1102-1111, Diabetologia, Heidelberg, Germany, C1-1
M Kebede, J Favaloro, J Gunton, D Laybutt, M Shaw, N Wong, B Fam, K Aston-Mourney, C Rantzau, A Zulli, J Proietto, S Andrikopoulos
(2008), Vol. 57, pp. 1887-1895, Diabetes, Alexandria, Va, C1-1
Too much of a good thing : why it is bad to stimulate the beta cell to secrete insulin
K Aston-Mourney, J Proietto, G Morahan, S Andrikopoulos
(2008), Vol. 51, pp. 540-545, Diabetologia, Heidelberg, Germany, C1-1
K Aston-Mourney, N Wong, M Kebede, S Zraika, L Balmer, J McMahon, B Fam, J Favaloro, J Proietto, G Morahan, S Andrikopoulos
(2007), Vol. 50, pp. 2476-2485, Diabetologia, Heidelberg, Germany, C1-1
S Zraika, K Aston-Mourney, D Laybutt, M Kebede, M Dunlop, J Proietto, S Andrikopoulos
(2006), Vol. 49, pp. 1254-1263, Diabetologia, Heidelberg, Germany, C1-1
Investigational agents that protect pancreatic islet β-cells from failure
K Aston-Mourney, J Proietto, S Andrikopoulos
(2005), Vol. 14, pp. 1241-1250, Expert opinion on investigational drugs, England, London, C1-1
S Andrikopoulos, C Massa, K Aston-Mourney, A Funkat, B Fam, R Hull, S Kahn, J Proietto
(2005), Vol. 187, pp. 45-53, Journal of endocrinology, Bristol, England, C1-1
S Kooptiwut, M Kebede, S Zraika, S Visinoni, K Aston-Mourney, J Favaloro, C Tikellis, M Thomas, J Forbes, M Cooper, M Dunlop, J Proietto, S Andrikopoulos
(2005), Vol. 35, pp. 39-48, Journal of molecular endocrinology, Bristol, England, C1-1
Funded Projects at Deakin
Australian Competitive Grants
A novel approach to target beta-cells to enhance survival and function
Dr Kathryn Aston-Mourney, A/Prof Sarah Shigdar, Prof Sean Mcgee
DART Grant - Research - Diabetes Australia - Victoria (Research Trust)
- 2020: $59,756
Other Public Sector Funding
MiSeq Next Generation Sequencer
Dr Kathryn Aston-Mourney
- 2013: $15,000
Industry and Other Funding
JDRF Travel Grant
Dr Kathryn Aston-Mourney
- 2012: $3,170
HDAC Inhibition as a Potential Therapy for Preventing the Progression of Type 2 Diabetes
Dr Kathryn Aston-Mourney, Prof Sean Mcgee
- 2015: $55,000
Generation and application of a novel screening tool for the Discovery of b-cell Protective Diabetes Drugs
Dr Kathryn Aston-Mourney
- 2015: $20,650
Discovery of novel therapies for type 2 diabetes
Dr Kathryn Aston-Mourney
- 2015: $32,000
Other Funding Sources
CASS Travel grant - American Diabetes Foundation
Dr Kathryn Aston-Mourney
- 2012: $3,000
Supervisions
Smithamol Sithara
Thesis entitled: A beta-cell specific global approach for drug identification in Type 2 Diabetes
Doctor of Philosophy (Medicine), School of Medicine